MRI mean diffusivity detects widespread brain degeneration in multiple sclerosis

Journal of the Neurological Sciences

Volumn 319, Issue 1-2, 2012, Pages 105-110

  Senda, Joe ^a   Watanabe, Hirohisa ^a   Tsuboi, Takashi ^a   Hara, Kazuhiro ^a   Watanabe, Hazuki ^a   Nakamura, Ryoichi ^a   Ito, Mizuki ^a   Atsuta, Naoki ^a   Tanaka, Fumiaki ^a   Naganawa, Shinji ^a   Sobue, Gen ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diffusion tensor imaging; FLAIR high intensity; Fractional anisotropy; Mean diffusivity; Multiple sclerosis; Voxel based morphometry

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN DEGENERATION; BRAIN SIZE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; DISEASE DURATION; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FLUID ATTENUATED INVERSION RECOVERY IMAGING; FRACTIONAL ANISOTROPY; FRONTAL LOBE; GRAY MATTER; HUMAN; HYPOTHALAMUS; LATERAL BRAIN VENTRICLE; LIMBIC CORTEX; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THALAMUS; VOLUMETRY; VOXEL BASED MORPHOMETRY; WHITE MATTER;

ADULT; AGED; BRAIN; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVE FIBERS, MYELINATED; NEUROIMAGING;

EID: 84862760061     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.04.019     Document Type: Article

References (39)

1. Pirko I, Lucchinetti CF, Sriram S, Bakshi R. Gray matter involvement in multiple sclerosis. Neurology 2007;68:634-42. (Pubitemid 46667808)
2. Ciccarelli O, Werring DJ, Barker GJ, Griffin CM, Wheeler-Kingshott CA, Miller DH, et al. A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging. J Neurol 2003;250:287-92. (Pubitemid 36399267)
3. Vrenken H, Pouwels PJ, Geurts JJ, Knol DL, Polman CH, Barkhof F, et al.Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging 2006;23:628-36.
4. Werring DJ, Clark CA, Barker GJ, Thompson AJ, Miller DH. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology 1999;52:1626-32. (Pubitemid 29220638)
5. Chard DT, Griffin CM, Rashid W, Davies GR, Altmann DR, Kapoor R, et al. Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis. Mult Scler 2004;10:387-91. (Pubitemid 39117333)
6. Dalton CM, Chard DT, Davies GR, Miszkiel KA, Altmann DR, Fernando K, et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004;127:1101-7. (Pubitemid 38623045)
7. Amato MP, Bartolozzi ML, Zipoli V, Portaccio E, Mortilla M, Guidi L, et al. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology 2004;63:89-93. (Pubitemid 38943784)
8. De Stefano N, Matthews PM, Filippi M, Agosta F, De Luca M, Bartolozzi ML, et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003;60:1157-62. (Pubitemid 36418778)
9. Sanfilipo MP, Benedict RH, Sharma J, Weinstock-Guttman B, Bakshi R. The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction. Neuroimage 2005;26:1068-77. (Pubitemid 40806485)
10. Sanfilipo MP, Benedict RH, Sharma J, Weinstock-Guttman B, Bakshi R. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology 2006;66:685-92. (Pubitemid 43739822)
11. Lublin FD, Reingold SC. Defining the clinical course ofmultiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-11.
12. Sachdev P, Wen W, Chen X, Brodaty H. Progression of white matter hyperintensities in elderly individuals over 3 years. Neurology 2007;68:214-22. (Pubitemid 46105740)
13. Murray ME, Senjem ML, Petersen RC, Hollman JH, Preboske GM, Weigand SD, et al. Functional impact of white matter hyperintensities in cognitively normal elderly subjects. Arch Neurol 2010;67:1379-85.
14. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2010;50:121-7.
15. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-9. (Pubitemid 43958540)
16. Jarius S, Paul F, Franciotta D,Waters P, Zipp F, Hohlfeld R, et al.Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 2008;4:202-14. (Pubitemid 351516748)
17. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
18. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1442-52.
19. Sharrak B, Hughes RAC. Clinical scales for multiple sclerosis. J Neurol Sci 1996;135:1-9. (Pubitemid 26019015)
20. Poline JB, Worsley KJ, Holmes AP, Frackowiak RS, Friston KJ. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995;2:189-210. (Pubitemid 124008664)
21. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007;38:95-113. (Pubitemid 47440133)
22. Raz E, Cercignani M, Sbardella E, Totaro P, Pozzilli C, Bozzali M, et al. Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging. Radiology 2010;257:448-54.
23. Gelineau-Morel R, Tomassini V, Jenkinson M, Johansen-Berg H, Matthews PM, Palace J. The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis. Hum Brain Mapp 2011 [Epub ahead of print].
24. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. Neuroimage 2000;11:805-21. (Pubitemid 30437668)
25. Masutani Y, Aoki S, Abe O, Hayashi N, Otomo K. MR diffusion tensor imaging: recent advance and new techniques for diffusion tensor visualization. Eur J Radiol 2003;46:53-66. (Pubitemid 36332079)
26. Duda R, Hart P, Stork D. Pattern classification. second edition. Wiley Interscience; 2000.
27. Mottershead JP, Schmierer K, Clemence M, Thornton JS, Scaravilli F, Barker GJ, et al. High field MRI correlates of myelin content and axonal density in multiple sclerosis - a post-mortem study of the spinal cord. J Neurol 2003;250:1293-301. (Pubitemid 37456888)
28. van Walderveen MA, Kamphorst W, Scheltens P, van Waesberghe JH, Ravid R, Valk J, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998;50:1282-8. (Pubitemid 28240340)
29. Schmierer K,Wheeler-Kingshott CA, Boulby PA, Scaravilli F, Altmann DR, Barker GJ, et al. Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage 2007;35:467-77. (Pubitemid 46400551)
30. Gass A, Niendorf T, Hirsch JG. Acute and chronic changes of the apparent diffusion coefficient in neurological disorders-biophysical mechanisms and possible underlying histopathology. J Neurol Sci 2001;186:S15-23.
31. Filippi M, Iannucci G, Cercignani M, Assunta Rocca M, Pratesi A, Comi G. A quantitative study of water diffusion in multiple sclerosis lesions and normalappearing white matter using echo-planar imaging. Arch Neurol 2000;57:1017-21. (Pubitemid 30452507)
32. Ceccarelli A, Rocca MA, Falini A, Tortorella P, Pagani E, Rodegher M, et al. Normal-appearing white and grey matter damage in MS. A volumetric and diffusion tensor MRI study at 3.0 Tesla. J Neurol 2007;254:513-8. (Pubitemid 46786729)
33. Lucchinetti C. Pathological heterogeneity of idiopathic central nervous system inflammatory demyelinating disorders. Curr Top Microbiol Immunol 2008;318:19-43.
34. Bö L, Geurts JJ, Mörk SJ, van der Valk P. Grey matter pathology in multiple sclerosis. Acta Neurol Scand 2006;183:48-50 (Suppl.).
35. Geurts JJ, Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol 2008;7:841-51.
36. Audoin B, Zaaraoui W, Reuter F, Rico A, Malikova I, Confort-Gouny S, et al. Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis. J Neurol Neurosurg Psychiatry 2010;81:690-5.
37. Sepulcre J, Sestre-Garriga J, Cercignani M, Ingle GT, Miller DH, Thomspon AJ. Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. Arch Neurol 2006;63:1175-80. (Pubitemid 44232328)
38. Wegner C, Esiri MM, Chance SA, Palace J, Matthews PM. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006;67:960-7. (Pubitemid 44454585)
39. Miller D, Barkhof F, Montalban X, Thompson A, Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005;4:281-8. (Pubitemid 40545039)